David Bharucha
Direttore Tecnico/Scientifico/R&S presso MILESTONE PHARMACEUTICALS INC.
Patrimonio netto: 23 890 $ in data 30/04/2024
Profilo
David B.
Bharucha is currently the Chief Medical Officer at Milestone Pharmaceuticals, Inc. Prior to this, he worked as the VP-Clinical Development, Research & Development at Allergan Ltd.
(Ireland) from 2018 to 2021.
Dr. Bharucha received his undergraduate degree from Haverford College and his doctorate degree from The University of Chicago.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2024 | 15 120 ( 0.03% ) | 23 890 $ | 30/04/2024 |
Posizioni attive di David Bharucha
| Società | Posizione | Inizio |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Direttore Tecnico/Scientifico/R&S | 15/02/2022 |
Precedenti posizioni note di David Bharucha
| Società | Posizione | Fine |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | 01/01/2021 |
Formazione di David Bharucha
| The University of Chicago | Doctorate Degree |
| Haverford College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- David Bharucha
